PFE
Pfizer, Inc.
Drug Manufacturers - General · Healthcare · United States
26.80
close · 2026-08-13
value
90
cheaper than peers90
quality
56
stronger fundamentals56
ranked against
Healthcare
value
quality
374 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 9.26× | 90 |
| EV to EBITDA | 7.93× | 86 |
| price to book | 1.79× | 82 |
| price to sales | 2.39× | 66 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 27.9% | 91 |
| return on equity | 5.0% | 67 |
| debt to equity | 74.3% | 33 |
| revenue growth | 2.6% | 25 |
4 of 4 measures available
Facts
| market cap | $153B |
| free cash flow | $12.49B |
| employees | 75,000 |
| first trade | 1972-06-01 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-07 |